pharmaceuticals

Regeneron Pharma beats Q3 earnings

Regeneron Pharma beats Q3 earnings

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third quarter earnings for fiscal year 2017 and beat analysts’ estimates, sending shares up almost 7 percent shortly after open on Wednesday.For the third quarter, Regeneron reported r..

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

Johnson & Johnson's Q3 Earnings Drop but Beat Estimates

On Tuesday, Johnson & Johnson (NYSE: JNJ) announced its financial results for the third quarter of 2017. The company also adjusted its guidance for full-year 2017 in the statement on Tuesday.For the third quarter of 2017, the company announced s..

National Institute of Health partners with 11 Biopharma companies for Cancer Research

National Institute of Health partners with 11 Biopharma companies for Cancer Research

The National Institutes of Health and 11 biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT). This is a five-year-public-private research collaboration totaling $215 million as part of the Cancer Moons..

Alnylam Pharmaceuticals Stock Jumps After Positive Phase 3 Trial Results

Alnylam Pharmaceuticals Stock Jumps After Positive Phase 3 Trial Results

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares jumped more than 40% after the pharma company, together with Sanofi Genzyme, the specialty care global business unit of Sanofi, announced that the APOLLO Phase 3 study of patisiran, an investigatio..

Valeant Pharmaceuticals Announced Q2 Earnings, Shares Jumped

Valeant Pharmaceuticals Announced Q2 Earnings, Shares Jumped

On Tuesday, Valeant Pharmaceuticals Intl Inc (NYSE: VRX) announced its financial results for the second quarter. With earnings beating estimates, shares of the company increased 7.6% to $16.54 per share in morning trading on Tuesday after the announ..

William Ackman to Take Stake in ADP

William Ackman to Take Stake in ADP

On Friday, billionaire investor William Ackman announced that he will be buying a large stake in Automatic Data Processing Inc.(NASDAQ:ADP),  a move that made the U.S. payroll company’s stock increase 16.5% to $120.In recent years, activi..

FDA Approves Adamis Pharmaceuticals' EpiPen Competitor

FDA Approves Adamis Pharmaceuticals' EpiPen Competitor

Adamis Pharmaceuticals Corp. (NASDAQ: ADMP) shares jumped more than 60% on Thursday, after the U.S Food and Drug Administration (FDA) approved the Adamis’ Epinephrine injection, a generic version of a Mylan N.V.’s EpiPen, which is a..